2024 annual financial data
PTC Therapeutics 2024 Operating margin
PTC Therapeutics 2024 operating margin with verified reported values.
Direct answer
Operating margin was -37.5%.
Operating income was -302,570,000 USD and net income was -363,295,000 USD.
Operating cash flow was -107,688,000 USD.
Get free PTC Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 806,780,000 USD
- Operating income
- -302,570,000 USD
- Net income
- -363,295,000 USD
- Operating cash flow
- -107,688,000 USD